Avecho Biotechnology Limited (ASX:AVE)

Avecho Biotechnology Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22	8	11	28	28	46
Market Cap Growth	16.82%	-28.57%	-59.76%	0.10%	-40.60%	634.85%
Enterprise Value	16	3	8	24	23	44
Last Close Price	0.01	0.00	0.00	0.01	0.01	0.03
PS Ratio	16.09	7.00	23.42	24.41	34.71	120.55
PB Ratio	26.92	2.42	1.74	11.37	6.07	17.47
P/TBV Ratio	26.92	2.42	1.74	11.49	6.21	20.85
P/OCF Ratio	18.64	-	-	-	-	-
EV/Sales Ratio	11.83	2.85	17.81	21.69	28.84	114.07
Debt / Equity Ratio	0.07	0.33	0.03	0.10	0.02	0.06
Debt / FCF Ratio	0.05	-	-	-	-	-
Asset Turnover	0.21	0.18	0.09	0.26	0.19	0.09
Inventory Turnover	4.46	3.93	2.07	1.12	1.93	1.16
Quick Ratio	4.46	2.70	7.83	2.97	6.31	3.90
Current Ratio	4.62	2.81	8.31	3.83	6.91	4.46
Return on Equity (ROE)	-143.71%	-64.72%	-78.08%	-67.30%	-95.01%	-71.08%
Return on Assets (ROA)	-33.53%	-31.11%	-40.10%	-33.99%	-49.50%	-40.56%
Return on Capital (ROIC)	-83.61%	-35.15%	-46.36%	-39.99%	-57.14%	-45.81%
Earnings Yield	-16.31%	-39.40%	-30.98%	-8.50%	-12.40%	-5.68%
FCF Yield	-	-50.09%	-28.67%	-6.23%	-11.99%	-3.08%
Buyback Yield / Dilution	-9.80%	-39.73%	-23.41%	-1.97%	-13.27%	-0.86%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.